Alain Gravet

995 total citations
19 papers, 477 citations indexed

About

Alain Gravet is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Alain Gravet has authored 19 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Epidemiology and 6 papers in Clinical Biochemistry. Recurrent topics in Alain Gravet's work include Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Mycobacterium research and diagnosis (4 papers). Alain Gravet is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Mycobacterium research and diagnosis (4 papers). Alain Gravet collaborates with scholars based in France, Switzerland and French Guiana. Alain Gravet's co-authors include Gilles Prévost, H. Monteil, Didier A. Colin, Daniel Keller, F. Grünenberger, Colette Harf‐Monteil, J.M. Scheftel, R Pradinaud, E. Clyti and Stéphane Bronner and has published in prestigious journals such as Applied and Environmental Microbiology, FEBS Letters and Journal of Clinical Microbiology.

In The Last Decade

Alain Gravet

18 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alain Gravet France 8 366 204 141 100 89 19 477
Kathryn Mackie Australia 4 453 1.2× 337 1.7× 135 1.0× 61 0.6× 103 1.2× 6 516
Anita Justice United Kingdom 2 563 1.5× 386 1.9× 161 1.1× 87 0.9× 147 1.7× 2 636
Eric R. McIndoo United States 8 434 1.2× 174 0.9× 154 1.1× 109 1.1× 256 2.9× 15 584
Olivia N. Chuang-Smith United States 9 312 0.9× 215 1.1× 67 0.5× 118 1.2× 109 1.2× 10 504
Karen Jacques-Palaz United States 9 333 0.9× 159 0.8× 82 0.6× 120 1.2× 109 1.2× 11 478
Antigoni Foka Greece 13 353 1.0× 268 1.3× 170 1.2× 67 0.7× 81 0.9× 25 509
Maria Sangvik Norway 9 210 0.6× 120 0.6× 68 0.5× 75 0.8× 77 0.9× 10 354
Yingxin Dai China 12 373 1.0× 307 1.5× 103 0.7× 90 0.9× 51 0.6× 22 619
G. E. Fosheim United States 6 397 1.1× 182 0.9× 207 1.5× 61 0.6× 131 1.5× 7 461
Ελεάννα Δρούγκα Greece 10 280 0.8× 183 0.9× 129 0.9× 69 0.7× 50 0.6× 17 379

Countries citing papers authored by Alain Gravet

Since Specialization
Citations

This map shows the geographic impact of Alain Gravet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Gravet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Gravet more than expected).

Fields of papers citing papers by Alain Gravet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Gravet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Gravet. The network helps show where Alain Gravet may publish in the future.

Co-authorship network of co-authors of Alain Gravet

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Gravet. A scholar is included among the top collaborators of Alain Gravet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Gravet. Alain Gravet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kaeuffer, Charlotte, Pierre Boyer, Nicolas Lefèbvre, et al.. (2023). Cefepime vs carbapenems for treating third-generation cephalosporin-resistant AmpC β-lactamase-hyperproducing Enterobacterales bloodstream infections: a multicenter retrospective study. International Journal of Infectious Diseases. 134. 273–279. 9 indexed citations
2.
Kaeuffer, Charlotte, et al.. (2023). Characteristics and Treatment of Gordonia spp. Bacteremia, France. Emerging infectious diseases. 29(5). 1025–1028. 2 indexed citations
3.
Gravet, Alain, et al.. (2022). Cholecystoduodenostomy for biliary obstruction treatment in a white‐collared lemur ( Eulemur cinereiceps ). Veterinary Record Case Reports. 10(4).
4.
Khanafer, Nagham, Benoît Guéry, Anne Vachée, et al.. (2021). Establishment of a French surveillance system of Clostridiodes difficile infection: Comparison of patient’s characteristics with other national and European data. Anaerobe. 69. 102329–102329. 1 indexed citations
5.
Sabou, Marcela, Wardi Moussaoui, Gilles Prévost, et al.. (2013). Comparison between the Biflex III-Biotyper and the Axima-SARAMIS Systems for Yeast Identification by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry. Journal of Clinical Microbiology. 51(4). 1231–1236. 42 indexed citations
6.
7.
Gravet, Alain, et al.. (2013). Spectrométrie de masse et microbiologie. Immuno-analyse & Biologie Spécialisée. 28(5-6). 297–308. 1 indexed citations
8.
Pina, P., Alain Gravet, Frédéric Laurent, et al.. (2011). Performance of a New MicroScan WalkAway PC30 Panel and Disk Diffusion Method for Detection of Oxacillin Resistance in Staphylococcus spp. Journal of Clinical Microbiology. 49(6). 2269–2271. 3 indexed citations
9.
Gravet, Alain, et al.. (2011). Application de la spectrométrie de masse à la microbiologie. Revue Francophone des Laboratoires. 2011(437). 55–64. 1 indexed citations
10.
Gravet, Alain, et al.. (2010). Bilan de l’utilisation en routine de la spectrométrie de masse dans un laboratoire hospitalier de microbiologie. Pathologie Biologie. 59(1). 19–25. 10 indexed citations
11.
Gravet, Alain, et al.. (2010). La culture et l’antibiogramme de mycobactéries sur automate VersaTREK. Pathologie Biologie. 59(1). 32–38. 7 indexed citations
12.
Kaltenbach, Georges, et al.. (2003). Caractéristiques des diarrhées postantibiotiques à Staphylococcus aureus. La Revue de Médecine Interne. 24. 129s–129s. 1 indexed citations
13.
Gravet, Alain, Pierre Couppié, Olivier Meunier, et al.. (2001). Staphylococcus aureus Isolated in Cases of Impetigo Produces Both Epidermolysin A or B and LukE-LukD in 78% of 131 Retrospective and Prospective Cases. Journal of Clinical Microbiology. 39(12). 4349–4356. 55 indexed citations
14.
Thomas, Isabelle, Patricia Mariani‐Kurkdjian, Anne Collignon, et al.. (2001). Breast Milk Transmission of a Panton-Valentine Leukocidin-Producing Staphylococcus aureus Strain Causing Infantile Pneumonia. Journal of Clinical Microbiology. 39(2). 728–729. 43 indexed citations
15.
Bronner, Stéphane, et al.. (2000). Variable Expressions of Staphylococcus aureus Bicomponent Leucotoxins Semiquantified by Competitive Reverse Transcription-PCR. Applied and Environmental Microbiology. 66(9). 3931–3938. 41 indexed citations
16.
Gravet, Alain, Colette Harf‐Monteil, F. Grünenberger, et al.. (1999). Predominant Staphylococcus aureus Isolated from Antibiotic-Associated Diarrhea Is Clinically Relevant and Produces Enterotoxin A and the Bicomponent Toxin LukE-LukD. Journal of Clinical Microbiology. 37(12). 4012–4019. 99 indexed citations
17.
Gravet, Alain, et al.. (1998). Characterization of a novel structural member, LukE‐LukD, of the bi‐component staphylococcal leucotoxins family. FEBS Letters. 436(2). 202–208. 142 indexed citations
18.
Couppié, Pierre, D. Sainte‐Marie, Gilles Prévost, et al.. (1998). [Impetigo in French Guyana. A clinical, bacteriological, toxicological and sensitivity to antibiotics study].. PubMed. 125(10). 688–93. 7 indexed citations
19.
Prévost, Gilles, Didier A. Colin, Leïla Staali, et al.. (1998). [Pore-forming leukotoxins from Staphylococcus aureus: variability of the target cells and 2 pharmacological processes].. PubMed. 46(6). 435–41. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathryn Mackie Breakdown of academic impact, for papers by Anita Justice Breakdown of academic impact, for papers by Eric R. McIndoo Breakdown of academic impact, for papers by Olivia N. Chuang-Smith Breakdown of academic impact, for papers by Karen Jacques-Palaz Breakdown of academic impact, for papers by Antigoni Foka Breakdown of academic impact, for papers by Maria Sangvik Breakdown of academic impact, for papers by Yingxin Dai Breakdown of academic impact, for papers by G. E. Fosheim Breakdown of academic impact, for papers by Ελεάννα Δρούγκα
Rankless by CCL
2026